Erelzi and Urination - excessive volume - a phase IV clinical study of FDA data

Summary:

Urination - excessive volume is reported as a side effect among people who take Erelzi (etanercept-szzs), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Celecoxib, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Urination - excessive volume when taking Erelzi. It is created by eHealthMe based on reports of 11,624 people who have side effects when taking Erelzi from the FDA, and is updated regularly.

What is Erelzi?

Erelzi has active ingredients of etanercept-szzs. eHealthMe is studying from 11,625 Erelzi users. Check the latest studies of Erelzi.

What is Urination - excessive volume?

Urination - excessive volume is found to be associated with 923 drugs and 1,309 conditions by eHealthMe. Check the latest studies of Urination - excessive volume.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

11,624 people reported to have side effects when taking Erelzi.
Among them, 11 people (0.09%) have Urination - excessive volume.

Could Erelzi cause Urination - excessive volume?

Among these 11 people:

How long have people been on Erelzi when they have Urination - excessive volume? *

What is the gender of people who have Urination - excessive volume when taking Erelzi? *

female: 90.91 %
male: 9.09 %

What is the age of people who have Urination - excessive volume when taking Erelzi? *

What are other drugs people take besides Erelzi? *

What are other side effects people have besides Urination - excessive volume? *

Pain: 10 people, 90.91%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 10 people, 90.91%
Spinal Cord Trauma: 10 people, 90.91%
Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve): 10 people, 90.91%
Polyarthritis (arthritis which involves 5 or more joints simultaneously): 10 people, 90.91%
Urge Incontinence (urinary incontinence): 10 people, 90.91%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 10 people, 90.91%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 10 people, 90.91%
Synovial Cyst (cyst of joint filled with synovial fluid): 9 people, 81.82%
Spinal Osteoarthritis (joint cartilage loss in spine): 9 people, 81.82%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Erelzi and have Urination - excessive volume?

- Check whether Urination - excessive volume is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Erelzi:

Erelzi (11,625 reports)

Browse all side effects of Erelzi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urination - excessive volume:

Urination - excessive volume (923 drugs)

Browse all the conditions that are associated with Urination - excessive volume:

Urination - excessive volume (1,309 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on etanercept-szzs (the active ingredients of Erelzi) and Erelzi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.